title: Lobular breast cancer: incidence and genetic and non-genetic risk factors.
abstract: While most invasive breast cancers consist of carcinomas of the ductal type, about 10% are invasive lobular carcinomas. Invasive lobular and ductal carcinomas differ with respect to risk factors. Invasive lobular carcinoma is more strongly associated with exposure to female hormones, and therefore its incidence is more subject to variation. This is illustrated by US figures during the 1987 to 2004 period: after 12 years of increases, breast cancer incidence declined steadily from 1999 to 2004, reflecting among other causes the decreasing use of menopausal hormone therapy, and these variations were stronger for invasive lobular than for invasive ductal carcinoma. Similarly, invasive lobular carcinoma is more strongly associated with early menarche, late menopause and late age at first birth. As for genetic risk factors, four high-penetrance genes are tested in clinical practice when genetic susceptibility to breast cancer is suspected, BRCA1, BRCA2, TP53 and CDH1. Germline mutations in BRCA1 and TP53 are predominantly associated with invasive ductal carcinoma, while BRCA2 mutations are associated with both ductal and lobular cancers. CDH1, the gene coding for the E-cadherin adhesion protein, is of special interest as mutations are associated with invasive lobular carcinoma, but never with ductal carcinoma. It was initially known as the main susceptibility gene for gastric cancer of the diffuse type, but the excess of breast cancers of the lobular type in CDH1 families led researchers to identify it also as a susceptibility gene for invasive lobular carcinoma. The risk of invasive lobular carcinoma is high in female mutation carriers, as about 50% are expected to develop the disease. Carriers must therefore undergo intensive breast cancer screening, with, for example, yearly magnetic resonance imaging and mammogram starting at age 30 years.
authors.forename: Laure
authors.initials: L
authors.lastname: Dossus
authors.forename: Patrick R
authors.initials: PR
authors.lastname: Benusiglio
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D018275:Carcinoma, Lobular / Q000453:epidemiology* / Q000209:etiology*; D004777:Environment; D005260:Female; D059647:Gene-Environment Interaction; D020022:Genetic Predisposition to Disease; D006801:Humans; D015994:Incidence; D012307:Risk Factors
references.citation: Br J Cancer. 2000 Nov;83(10):1301-8
references.pmid: 11044354
references.citation: Int J Cancer. 2001 Jun 15;92(6):919-22
references.pmid: 11351317
references.citation: Breast Cancer Res. 2001;3(5):289-93
references.pmid: 11597316
references.citation: Lancet. 2001 Oct 27;358(9291):1389-99
references.pmid: 11705483
references.citation: Gastroenterology. 2001 Dec;121(6):1348-53
references.pmid: 11729114
references.citation: J Clin Oncol. 2002 Feb 1;20(3):699-706
references.pmid: 11821451
references.citation: JAMA. 2002 Feb 13;287(6):734-41
references.pmid: 11851540
references.citation: Breast Cancer Res Treat. 2002 Mar;72(2):107-15
references.pmid: 12038701
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600
references.pmid: 12101105
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: Lancet. 2002 Jul 20;360(9328):187-95
references.pmid: 12133652
references.citation: Cancer. 2002 Dec 15;95(12):2455-64
references.pmid: 12467057
references.citation: JAMA. 2003 Mar 19;289(11):1421-4
references.pmid: 12636465
references.citation: Cancer Causes Control. 2003 Apr;14(3):225-33
references.pmid: 12814201
references.citation: JAMA. 2003 Jun 25;289(24):3243-53
references.pmid: 12824205
references.citation: JAMA. 2003 Jun 25;289(24):3254-63
references.pmid: 12824206
references.citation: Breast Cancer Res. 2003;5(5):239-47
references.pmid: 12927032
references.citation: Int J Cancer. 2003 Nov 20;107(4):647-51
references.pmid: 14520705
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1061-6
references.pmid: 14578143
references.citation: Cancer. 2004 Jun 1;100(11):2328-37
references.pmid: 15160335
references.citation: Cancer. 1982 May 1;49(9):1937-40
references.pmid: 6280850
references.citation: Br J Cancer. 1988 Jul;58(1):99-104
references.pmid: 3166899
references.citation: Cancer Res. 1994 May 1;54(9):2378-85
references.pmid: 8162584
references.citation: Cancer Res. 1994 Jul 15;54(14):3845-52
references.pmid: 8033105
references.citation: Science. 1994 Oct 7;266(5182):66-71
references.pmid: 7545954
references.citation: Am J Epidemiol. 1994 Dec 1;140(11):980-8
references.pmid: 7985660
references.citation: Nature. 1995 Dec 21-28;378(6559):789-92
references.pmid: 8524414
references.citation: Lancet. 1996 Jun 22;347(9017):1713-27
references.pmid: 8656904
references.citation: Am J Hum Genet. 1998 Mar;62(3):676-89
references.pmid: 9497246
references.citation: Nature. 1998 Mar 26;392(6674):402-5
references.pmid: 9537325
references.citation: Cancer Res. 1998 Sep 15;58(18):4086-9
references.pmid: 9751616
references.citation: Hum Mol Genet. 1999 Apr;8(4):607-10
references.pmid: 10072428
references.citation: Int J Cancer. 1999 Mar 31;81(1):49-55
references.pmid: 10077152
references.citation: Lancet. 1997 Oct 11;350(9084):1047-59
references.pmid: 10213546
references.citation: Am J Pathol. 1999 Aug;155(2):337-42
references.pmid: 10433926
references.citation: Hum Mutat. 1999;14(3):249-55
references.pmid: 10477433
references.citation: Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s
references.pmid: 15701886
references.citation: Clin Cancer Res. 2005 Aug 1;11(15):5401-9
references.pmid: 16061854
references.citation: Br J Cancer. 2005 Aug 8;93(3):364-71
references.pmid: 16079783
references.citation: Br J Cancer. 2005 Oct 31;93(9):1046-52
references.pmid: 16175185
references.citation: Breast Cancer Res Treat. 2008 Jan;107(1):103-11
references.pmid: 17333341
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2773-80
references.pmid: 18086787
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):43-50
references.pmid: 18199710
references.citation: Am J Epidemiol. 2008 Jan 15;167(2):230-9
references.pmid: 17965112
references.citation: J Clin Oncol. 2008 Mar 10;26(8):1260-8
references.pmid: 18323549
references.citation: J Clin Oncol. 2008 Jun 20;26(18):3073-82
references.pmid: 18519949
references.citation: Int J Cancer. 2008 Aug 15;123(4):933-41
references.pmid: 18506692
references.citation: Am J Surg Pathol. 2010 Oct;34(10):1472-9
references.pmid: 20871222
references.citation: J Med Genet. 2011 Jan;48(1):64-8
references.pmid: 20921021
references.citation: Nat Rev Mol Cell Biol. 2011 Mar;12(3):189-97
references.pmid: 21346732
references.citation: Breast Cancer Res. 2010;12(6):R106
references.pmid: 21143857
references.citation: Clin Cancer Res. 2011 Mar 1;17(5):1082-9
references.pmid: 21233401
references.citation: Cancer. 2011 May 1;117(9):1946-56
references.pmid: 21509772
references.citation: Ann Oncol. 2011 Sep;22 Suppl 6:vi31-4
references.pmid: 21908500
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
references.pmid: 22144499
references.citation: Clin Cancer Res. 2012 Jan 15;18(2):400-7
references.pmid: 22252256
references.citation: Lancet Oncol. 2012 May;13(5):476-86
references.pmid: 22401913
references.citation: Breast Cancer Res Treat. 2012 Jun;133(3):1125-30
references.pmid: 22392042
references.citation: Clin Genet. 2012 Aug;82(2):105-14
references.pmid: 22356477
references.citation: Breast Cancer Res Treat. 2012 Aug;134(3):1209-20
references.pmid: 22527103
references.citation: Am J Surg Pathol. 2012 Nov;36(11):1709-17
references.pmid: 23073328
references.citation: Lancet Oncol. 2012 Nov;13(11):1141-51
references.pmid: 23084519
references.citation: Eur J Contracept Reprod Health Care. 2012 Dec;17(6):402-14
references.pmid: 23061743
references.citation: J Mammary Gland Biol Neoplasia. 2013 Mar;18(1):25-42
references.pmid: 23392570
references.citation: Histopathology. 2013 Apr;62(5):695-701
references.pmid: 23347178
references.citation: J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
references.pmid: 23628597
references.citation: J Med Genet. 2013 Jul;50(7):486-9
references.pmid: 23709761
references.citation: Am J Epidemiol. 2013 Aug 1;178(3):359-71
references.pmid: 23899816
references.citation: Br J Cancer. 2014 Feb 18;110(4):1053-7
references.pmid: 24366306
references.citation: Science. 2014 Mar 28;343(6178):1466-70
references.pmid: 24675953
references.citation: PLoS Genet. 2014 Apr;10(4):e1004285
references.pmid: 24743323
references.citation: Breast Cancer Res Treat. 2014 Jun;145(2):481-9
references.pmid: 24748570
references.citation: Hum Mutat. 2014 Jun;35(6):654-62
references.pmid: 24706533
references.citation: Int J Cancer. 2006 Mar 1;118(5):1285-91
references.pmid: 16170777
references.citation: Breast Cancer Res. 2006;8(1):R11
references.pmid: 16507159
references.citation: JAMA. 2006 Apr 12;295(14):1647-57
references.pmid: 16609086
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):946-54
references.pmid: 16702375
references.citation: Cancer. 2006 Jul 1;107(1):12-21
references.pmid: 16718671
references.citation: Br J Cancer. 2006 Jul 3;95(1):123-9
references.pmid: 16755295
references.citation: Lancet Oncol. 2006 Nov;7(11):910-8
references.pmid: 17081916
references.citation: JAMA. 2007 Jun 6;297(21):2360-72
references.pmid: 17545690
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2144-9
references.pmid: 17932363
references.citation: J Med Genet. 2007 Nov;44(11):726-31
references.pmid: 17660459
references.citation: Br J Cancer. 2000 Jun;82(12):1932-7
references.pmid: 10864200
references.citation: Cancer. 2000 Jun 1;88(11):2570-7
references.pmid: 10861435
references.citation: N Engl J Med. 2000 Jul 13;343(2):78-85
references.pmid: 10891514
references.citation: Breast Cancer Res Treat. 2008 Oct;111(3):559-68
references.pmid: 17990099
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3150-60
references.pmid: 18990757
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3402-10
references.pmid: 19029400
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3427-34
references.pmid: 19064558
references.citation: Br J Cancer. 2009 Feb 10;100(3):538-44
references.pmid: 19190634
references.citation: Cancer. 2009 Mar 1;115(5):936-45
references.pmid: 19156895
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96
references.pmid: 19336542
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1763-9
references.pmid: 19454615
references.citation: Ann Surg Oncol. 2009 Jul;16(7):1890-5
references.pmid: 19408054
references.citation: Am J Epidemiol. 2009 Aug 1;170(3):308-17
references.pmid: 19541857
references.citation: Breast Cancer Res. 2009;11(3):206
references.pmid: 19519952
references.citation: Int J Cancer. 2009 Oct 15;125(8):1926-34
references.pmid: 19569233
references.citation: Br J Cancer. 2010 Mar 30;102(7):1091-8
references.pmid: 20234365
references.citation: Am J Gastroenterol. 2010 Jun;105(6):1258-64; author reply 1265
references.pmid: 20051941
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54
references.pmid: 20501751
references.citation: J Med Genet. 2010 Jul;47(7):436-44
references.pmid: 20591882
references.citation: J Natl Cancer Inst. 2010 Sep 22;102(18):1422-31
references.pmid: 20733117